SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-040970
Filing Date
2015-05-11
Accepted
2015-05-11 13:40:44
Documents
2
Period of Report
2015-05-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1543
2 POA DOCUMENT poa.txt EX-24.3_581099 3167
  Complete submission text file 0001209191-15-040970.txt   6158
Mailing Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709
Business Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709 919-313-9650
AERIE PHARMACEUTICALS INC (Issuer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O AERIE PHARMACEUTICALS, INC. 2030 MAIN STREET, SUITE 1500 IRVINE CA 92614
Business Address
Croarkin Richard (Reporting) CIK: 0001641815 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36152 | Film No.: 15849899